Introduction

Beyond diagnostics, smart pills are being positioned as tools for treatment and patient management. Polaris Market Research reports that the smart pills market was valued at USD 1.0 billion in 2025 and is expected to reach USD 4.1 billion by 2034, growing at a CAGR of 18.90% from 2026 to 2034. The market is segmented by application, target area, end use and region.

This article covers drug delivery, demographic demand, target areas, end users and the regional outlook.

Drug Delivery and Monitoring Applications

The market is propelled in part by increasing demand for advanced drug delivery systems. The report lists benefits including optimal utilization of active pharmaceutical ingredients, reduced dosage frequency, minimal adverse effects, targeted drug delivery and safer carriers. Advanced drug delivery products are expected to find a substantial customer base among patients with chronic diseases who require precise medication dosing at the targeted site. The report anticipates that integrating innovative drugs, medical devices and advanced technologies will drive further growth.

Application segments also include vital sign monitoring, alongside capsule endoscopy and targeted drug delivery. Related developments show how monitoring and adherence tools are evolving. In April 2025, Centor launched a smart pill organizer that uses LTE connectivity for real-time medication adherence monitoring, enabling pharmacies to offer remote care without requiring patient app setup or configuration.

Capsule endoscopy remains the largest application, with a 46.3% share in 2025, so drug delivery and monitoring represent additional avenues alongside it. The report also cites the burgeoning demand for minimally invasive procedures and technological advancements, including the miniaturization of integrated circuits, as factors expected to propel growth.

Demographics Driving Demand

The report names the growing geriatric population as a key driving factor. Potential customers for smart pills include individuals with paralysis, immobile patients and the geriatric population, and the increasing number of older adults is expected to drive demand for advanced medical devices that enhance patient convenience.

NCBI data cited in the report illustrate the scale in the United States. The population aged 50 and older is expected to rise by 61.1%, from 137.2 million in 2020 to 221.1 million by 2050. The number of people aged 50 with at least one medical condition is projected to grow by nearly 99.5%, reaching 142.7 million by 2050 from 71.5 million in 2020. Individuals with multimorbidity are estimated to increase by 91.2%, from 7.8 million in 2020 to 14.9 million in 2050. Globally, the population is expected to grow from 8 billion to 9.7 billion by 2050.

Analysts forecast a continuous increase in the global population, with a potential peak of approximately 10.4 billion around the mid-2080s. The report describes this trajectory as presenting both challenges and opportunities for sustainability, resource management and global development.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

https://www.polarismarketresearch.com/industry-analysis/smart-pills-market 

Target Areas and End Users

By target area, the market covers the esophagus, small intestine, large intestine and stomach. The small intestine segment held the largest share in 2025, at 44.1%, bolstered by the increasing prevalence of small intestine disorders, including Crohn’s disease and celiac disease.

By end use, the market covers hospitals, diagnostic centers and others. The hospitals segment is expected to record the highest CAGR, at 19.8%, supported by the availability of advanced diagnostic technologies, specialized healthcare professionals and comprehensive treatment facilities.

Regional Outlook

North America led the global market with a 40.7% share in 2025. The report cites rapid technological advancements in healthcare, high adoption of minimally invasive diagnostic technologies and the increasing prevalence of colorectal cancer and gastrointestinal disorders. According to the WHO, colorectal cancer is the third most common cancer globally, constituting approximately 10% of all cancer cases, and the second leading cause of cancer-related deaths.

Asia Pacific is projected to register the highest CAGR, at 20.6%, driven by increasing investments in healthcare technologies, expanding healthcare infrastructure and a surging prevalence of stomach cancer and gastrointestinal diseases. In 2020, reported gastric cancer cases worldwide exceeded 1 million, leading to 769,000 deaths, and countries including Japan, Mongolia and China show higher incidence rates.

The report adds that, despite an overall decline in gastric cancer incidence, there has been a troubling increase in cases among young adults over the past few decades.

The report expects North America’s dominance to persist throughout the forecast period, citing technological advancements in healthcare, a rise in colorectal cancer cases and regulatory approvals for new products.

AI and Personalized Care

AI is also expected to support personalized treatment by helping analyze patient-specific data collected from smart pills, assisting in personalized therapy decisions.

Key Players

Major players include CapsoVision, Inc., Medisafe, Medtronic, Olympus Corporation and Otsuka Holdings Co., Ltd. One example of product activity is Novo Nordisk’s introduction of Semaglutide, an anti-diabetes pill, in India in 2022, offering a new treatment option for individuals managing type 2 diabetes.

The report’s company profiles cover each player’s overview, financial performance, product benchmarking and recent developments.

Conclusion

Demographics, chronic disease management and demand for precise dosing give the smart pills market durable drivers beyond diagnostics. With North America leading and Asia Pacific posting the fastest regional growth, suppliers have clear priorities, while hospitals remain the fastest-growing end-use setting.

More Trending Latest Reports By Polaris Market Research:

Data Diode Market

Healthcare Payer Services Market

Health Information Exchange Market

Healthcare Services Market

Vector Database Market

Alternatives Protein Market

Glass Interposers Market

Industrial Hemp Market

Medical Device Contract Manufacturing Market